Cargando…

The Adenylate Cyclase Activator Forskolin Potentiates the Positive Inotropic Effect of the Phosphodiesterase Inhibitor Milrinone But Not of the Calcium Sensitizer Levosimendan nor of Its Hemodynamically Active Metabolites: An Apparent Conundrum

OR-1855 and OR-1896 are 2 hemodynamically active metabolites of the inodilator levosimendan, with calcium sensitizing activity, but their mechanism of action is still not fully understood. It has been previously reported that the positive inotropic effect of levosimendan is not potentiated by the ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Levijoki, Jouko, Pollesello, Piero, Grossini, Elena, Papp, Zoltán
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of Cardiovascular Pharmacology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162272/
https://www.ncbi.nlm.nih.gov/pubmed/35170487
http://dx.doi.org/10.1097/FJC.0000000000001235
_version_ 1784719663156953088
author Levijoki, Jouko
Pollesello, Piero
Grossini, Elena
Papp, Zoltán
author_facet Levijoki, Jouko
Pollesello, Piero
Grossini, Elena
Papp, Zoltán
author_sort Levijoki, Jouko
collection PubMed
description OR-1855 and OR-1896 are 2 hemodynamically active metabolites of the inodilator levosimendan, with calcium sensitizing activity, but their mechanism of action is still not fully understood. It has been previously reported that the positive inotropic effect of levosimendan is not potentiated by the adenylate cyclase activator forskolin, whereas forskolin does potentiate the effects of the phosphodiesterase (PDE) inhibitor milrinone. To ascertain whether the active metabolites follow the same pattern of levosimendan, the positive inotropic effects of OR- 1855 and OR-1896 were studied in guinea-pig-isolated papillary muscle in the presence and absence of forskolin. OR-1855 and OR-1896 were also tested as inhibitors of PDE-III and PDE-IV. Our results show that 0.1 µM forskolin did not potentiate the positive inotropic effect of OR-1855 or OR-1896, as in the case of the parent compound levosimendan. As in previous studies, the positive inotropic effect of milrinone was markedly potentiated in the presence of forskolin. From these data, we propose an explanation for the divergent behavior of the calcium sensitizing drugs and PDE inhibitors.
format Online
Article
Text
id pubmed-9162272
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Journal of Cardiovascular Pharmacology
record_format MEDLINE/PubMed
spelling pubmed-91622722022-06-08 The Adenylate Cyclase Activator Forskolin Potentiates the Positive Inotropic Effect of the Phosphodiesterase Inhibitor Milrinone But Not of the Calcium Sensitizer Levosimendan nor of Its Hemodynamically Active Metabolites: An Apparent Conundrum Levijoki, Jouko Pollesello, Piero Grossini, Elena Papp, Zoltán J Cardiovasc Pharmacol Original Article OR-1855 and OR-1896 are 2 hemodynamically active metabolites of the inodilator levosimendan, with calcium sensitizing activity, but their mechanism of action is still not fully understood. It has been previously reported that the positive inotropic effect of levosimendan is not potentiated by the adenylate cyclase activator forskolin, whereas forskolin does potentiate the effects of the phosphodiesterase (PDE) inhibitor milrinone. To ascertain whether the active metabolites follow the same pattern of levosimendan, the positive inotropic effects of OR- 1855 and OR-1896 were studied in guinea-pig-isolated papillary muscle in the presence and absence of forskolin. OR-1855 and OR-1896 were also tested as inhibitors of PDE-III and PDE-IV. Our results show that 0.1 µM forskolin did not potentiate the positive inotropic effect of OR-1855 or OR-1896, as in the case of the parent compound levosimendan. As in previous studies, the positive inotropic effect of milrinone was markedly potentiated in the presence of forskolin. From these data, we propose an explanation for the divergent behavior of the calcium sensitizing drugs and PDE inhibitors. Journal of Cardiovascular Pharmacology 2022-06 2022-02-16 /pmc/articles/PMC9162272/ /pubmed/35170487 http://dx.doi.org/10.1097/FJC.0000000000001235 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Original Article
Levijoki, Jouko
Pollesello, Piero
Grossini, Elena
Papp, Zoltán
The Adenylate Cyclase Activator Forskolin Potentiates the Positive Inotropic Effect of the Phosphodiesterase Inhibitor Milrinone But Not of the Calcium Sensitizer Levosimendan nor of Its Hemodynamically Active Metabolites: An Apparent Conundrum
title The Adenylate Cyclase Activator Forskolin Potentiates the Positive Inotropic Effect of the Phosphodiesterase Inhibitor Milrinone But Not of the Calcium Sensitizer Levosimendan nor of Its Hemodynamically Active Metabolites: An Apparent Conundrum
title_full The Adenylate Cyclase Activator Forskolin Potentiates the Positive Inotropic Effect of the Phosphodiesterase Inhibitor Milrinone But Not of the Calcium Sensitizer Levosimendan nor of Its Hemodynamically Active Metabolites: An Apparent Conundrum
title_fullStr The Adenylate Cyclase Activator Forskolin Potentiates the Positive Inotropic Effect of the Phosphodiesterase Inhibitor Milrinone But Not of the Calcium Sensitizer Levosimendan nor of Its Hemodynamically Active Metabolites: An Apparent Conundrum
title_full_unstemmed The Adenylate Cyclase Activator Forskolin Potentiates the Positive Inotropic Effect of the Phosphodiesterase Inhibitor Milrinone But Not of the Calcium Sensitizer Levosimendan nor of Its Hemodynamically Active Metabolites: An Apparent Conundrum
title_short The Adenylate Cyclase Activator Forskolin Potentiates the Positive Inotropic Effect of the Phosphodiesterase Inhibitor Milrinone But Not of the Calcium Sensitizer Levosimendan nor of Its Hemodynamically Active Metabolites: An Apparent Conundrum
title_sort adenylate cyclase activator forskolin potentiates the positive inotropic effect of the phosphodiesterase inhibitor milrinone but not of the calcium sensitizer levosimendan nor of its hemodynamically active metabolites: an apparent conundrum
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162272/
https://www.ncbi.nlm.nih.gov/pubmed/35170487
http://dx.doi.org/10.1097/FJC.0000000000001235
work_keys_str_mv AT levijokijouko theadenylatecyclaseactivatorforskolinpotentiatesthepositiveinotropiceffectofthephosphodiesteraseinhibitormilrinonebutnotofthecalciumsensitizerlevosimendannorofitshemodynamicallyactivemetabolitesanapparentconundrum
AT pollesellopiero theadenylatecyclaseactivatorforskolinpotentiatesthepositiveinotropiceffectofthephosphodiesteraseinhibitormilrinonebutnotofthecalciumsensitizerlevosimendannorofitshemodynamicallyactivemetabolitesanapparentconundrum
AT grossinielena theadenylatecyclaseactivatorforskolinpotentiatesthepositiveinotropiceffectofthephosphodiesteraseinhibitormilrinonebutnotofthecalciumsensitizerlevosimendannorofitshemodynamicallyactivemetabolitesanapparentconundrum
AT pappzoltan theadenylatecyclaseactivatorforskolinpotentiatesthepositiveinotropiceffectofthephosphodiesteraseinhibitormilrinonebutnotofthecalciumsensitizerlevosimendannorofitshemodynamicallyactivemetabolitesanapparentconundrum
AT levijokijouko adenylatecyclaseactivatorforskolinpotentiatesthepositiveinotropiceffectofthephosphodiesteraseinhibitormilrinonebutnotofthecalciumsensitizerlevosimendannorofitshemodynamicallyactivemetabolitesanapparentconundrum
AT pollesellopiero adenylatecyclaseactivatorforskolinpotentiatesthepositiveinotropiceffectofthephosphodiesteraseinhibitormilrinonebutnotofthecalciumsensitizerlevosimendannorofitshemodynamicallyactivemetabolitesanapparentconundrum
AT grossinielena adenylatecyclaseactivatorforskolinpotentiatesthepositiveinotropiceffectofthephosphodiesteraseinhibitormilrinonebutnotofthecalciumsensitizerlevosimendannorofitshemodynamicallyactivemetabolitesanapparentconundrum
AT pappzoltan adenylatecyclaseactivatorforskolinpotentiatesthepositiveinotropiceffectofthephosphodiesteraseinhibitormilrinonebutnotofthecalciumsensitizerlevosimendannorofitshemodynamicallyactivemetabolitesanapparentconundrum